Juvelook 50mg: Regulatory Status and Sourcing for Professional Use

Juvelook 50mg is a poly D,L-lactic acid (PDLLA) based collagen biostimulator, formulated to stimulate natural collagen production. Manufactured by Pharma Research in South Korea, it is designed for professional aesthetic applications. This product is distinct from other offerings like Juvelook Volume 200mg, which typically contains a higher concentration for different treatment areas. As with any product in the Body collagen biostimulator catalog, such as Olidia, clinics must prioritize regulatory compliance and product integrity.

For products originating from South Korea, KFDA (Korean Ministry of Food and Drug Safety) approval is a fundamental certification, indicating local market authorization. The presence of CE marking (Conformité Européenne) is essential for legal distribution within the European Union and often influences acceptance in other markets. FDA (U.S. Food and Drug Administration) approval for aesthetic injectables is a stringent benchmark, while GMP (Good Manufacturing Practice) and ISO (International Organization for Standardization) certifications attest to manufacturing quality and safety standards.

Juvelook 50mg Specific Status:

• KFDA: [VERIFY: Juvelook 50mg is registered with KFDA for its intended use in South Korea.]
• CE Mark: [VERIFY: Juvelook 50mg does not hold a CE Mark as a Class III medical device for EU market access.]
• FDA: [VERIFY: Juvelook 50mg is not FDA-approved for marketing in the United States.]
• GMP/ISO: Pharma Research facilities typically adhere to GMP guidelines and ISO standards. [VERIFY: Specific ISO certification numbers for Juvelook 50mg production line if available.]

The European Union and the United Kingdom maintain distinct but often similar regulatory pathways for aesthetic medical devices. For legal market entry as a Class III injectable, a CE Mark issued under the Medical Device Regulation (MDR) is required in the EU. Without this, importation and distribution within the EU/UK are restricted. Professionals sourcing Juvelook 50mg for these markets must ensure compliance with national regulations regarding unregistered or "off-label" products, which vary significantly by country. For comparison, other biostimulators like Metoo Fill+ Regulatory Status: Essential Insights for Profes also navigate complex regional requirements.

The Gulf Cooperation Council (GCC) countries and Latin American (LATAM) markets each possess unique regulatory frameworks for aesthetic products. Registration with national health authorities (e.g., SFDA in Saudi Arabia, MOH in UAE, ANVISA in Brazil, COFEPRIS in Mexico) is typically required for official market entry. The acceptance of products like Juvelook 50mg often relies on documentation of manufacturer origin, GMP compliance, and in some cases, prior registration in reference countries. Clinics in these regions should confirm the specific import and usage regulations applicable to their locale, similar to considerations for products like Aesthefill Standard.

Parallel imports involve sourcing authentic products from a country where they are legally marketed, for import into another country where they may or may not be officially registered. While the product itself may be original, parallel importation often bypasses national regulatory approval processes, making traceability and quality assurance challenging. Clinics must be aware that using parallel-imported products can carry legal and professional risks, particularly concerning insurance coverage and potential liability. Ensuring proper documentation and supplier transparency is paramount.

When sourcing Juvelook 50mg, aesthetic professionals must demand comprehensive documentation from their suppliers. This includes certificates of analysis (COA) for specific batches, proof of cold chain maintenance, and verifiable lot numbers. An original manufacturer's certificate of authenticity, where available, provides an additional layer of assurance. Suppliers should also provide evidence of their own regulatory compliance as a distributor, ensuring a transparent and legitimate supply chain.

Wholesale pricing for Juvelook 50mg is structured to accommodate professional buying volumes. An illustrative base price for a single unit is approximately $217.0. Volume-based tiers offer incremental discounts:

These structures allow clinics to manage inventory costs effectively while maintaining access to authentic products.